Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

All

ATC ↓	Name	B/G	Ingredients	Dosage	Form	Price
R06AB52	HISTAMED-F	G	Dexchlorpheniramine - 2mg/5ml, Dexamethasone - 0.25mg/5ml		Syrup	712,876 L.L
R06AB52	HISTAMED-F	G	Dexchlorpheniramine maleate - 2mg, Dexamethasone - 0.25mg, Fluphenazine HCl - 0.25mg		Tablet, coated	579,772 L.L
R06AB02	HISTAMED	G	Dexchlorpheniramine maleate - 1%	1%	Gel	477,384 L.L
R06AA52	HISTALIX	G	Diphenhydramine HCl - 14mg/5ml, Ammonium chloride - 135mg/5ml, Menthol - 1.1mg/5ml		Syrup	405,840 L.L
R05CA12	HEDECTON COUGH	G	Dried Ivy leaf extract - 40mg/5ml		Syrup	467,657 L.L
R02AA20	HEXASPRAY COLLUTOIRE PRESSURISE	B	Biclotymol - 750mg	750mg	Spray	353,431 L.L
N05CD08	HIKMA MIDAZOLAM	G	Midazolam (HCl) - 5mg/ml	5mg/ml	Injectable solution	679,984 L.L
N05AD01	HALDOL	B	Haloperidol - 5mg	5mg	Tablet	231,141 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 5mg	5mg	Tablet	276,448 L.L
N05AD01	HALDOL DECANOAS	B	Haloperidol (Decanoate) - 50mg/ml	50mg/ml	Injectable solution	444,812 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 2mg	2mg	Tablet	252,130 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 10mg	10mg	Tablet	339,160 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 20mg	20mg	Tablet	339,160 L.L
N02BE51	HUMACE PLUS	G	Paracetamol - 500mg, Aceclofenac (potassium) - 200mg		Tablet	575,165 L.L
N02BE51	HUMEXLIB PARACETAMOL CHLORPHENAMINE	B	Paracetamol - 500mg, Chlorphenamine maleate - 4mg		Capsule	598,010 L.L
N02BE51	HUMEX RHUME	B	Pseudoephedrine HCl (tablet) - 60mg, Paracetamol (tablet) - 500mg, Paracetamol (capsule) - 500mg, Chlorphenamine maleate (capsule) - 4mg		Tablet, capsule	467,657 L.L
M09AX01	HYALGAN	B	Hyaluronic acid (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	3,407,985 L.L
M01AE03	HUMFINE	G	Ketoprofen - 100mg/2ml	100mg/2ml	Injectable solution	3,514,148 L.L
L04AB04	HUMIRA	BioTech	Adalimumab - 40mg/0.4ml	40mg/0.4ml	Injectable solution	33,860,031 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	682,013 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	682,013 L.L
L04AB04	HUMIRA	BioTech	Adalimumab - 80mg/0.8ml	80mg/0.8ml	Injectable solution	33,860,031 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	26,715,144 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	26,715,144 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	6,048,090 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	36,967,093 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution	89,170,219 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	36,112,482 L.L
L01FD01	HERCEPTIN	BioTech	Trastuzumab - 440mg	21mg/ml	Injectable concentrated powder for solution+diluent	166,423,476 L.L
L01FD01	HERCEPTIN	BioTech	Trastuzumab - 440mg	21mg/ml	Injectable concentrated powder for solution+diluent	166,423,476 L.L